What is the official website of PHAXIAM Therapeutics ?

The official website of PHAXIAM Therapeutics is http://www.phaxiam.com.

What is PHAXIAM Therapeutics's cybersecurity risk score?

PHAXIAM Therapeutics has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has PHAXIAM Therapeutics experienced?

According to Rankiteo, PHAXIAM Therapeutics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has PHAXIAM Therapeutics been affected by any supply chain cyber incidents ?

According to Rankiteo, PHAXIAM Therapeutics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does PHAXIAM Therapeutics have SOC 2 Type 1 certification ?

According to Rankiteo, PHAXIAM Therapeutics is not certified under SOC 2 Type 1.

Does PHAXIAM Therapeutics have SOC 2 Type 2 certification ?

According to Rankiteo, PHAXIAM Therapeutics does not hold a SOC 2 Type 2 certification.

Does PHAXIAM Therapeutics comply with GDPR ?

According to Rankiteo, PHAXIAM Therapeutics is not listed as GDPR compliant.

Does PHAXIAM Therapeutics have PCI DSS certification ?

According to Rankiteo, PHAXIAM Therapeutics does not currently maintain PCI DSS compliance.

Does PHAXIAM Therapeutics comply with HIPAA ?

According to Rankiteo, PHAXIAM Therapeutics is not compliant with HIPAA regulations.

Does PHAXIAM Therapeutics have ISO 27001 certification ?

According to Rankiteo,PHAXIAM Therapeutics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does PHAXIAM Therapeutics operate in ?

PHAXIAM Therapeutics operates primarily in the Biotechnology industry.

How many employees does PHAXIAM Therapeutics have ?

PHAXIAM Therapeutics employs approximately 61 people worldwide.

Does PHAXIAM Therapeutics own any subsidiaries ?

PHAXIAM Therapeutics presently has no subsidiaries across any sectors.

How many LinkedIn followers does PHAXIAM Therapeutics have ?

PHAXIAM Therapeutics's official LinkedIn profile has approximately 20,862 followers.

Does PHAXIAM Therapeutics have a Crunchbase profile ?

No, PHAXIAM Therapeutics does not have a profile on Crunchbase.

Does PHAXIAM Therapeutics have a LinkedIn profile ?

Yes, PHAXIAM Therapeutics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/phaxiam.

How many cybersecurity incidents has PHAXIAM Therapeutics experienced ?

As of August 25, 2026, Rankiteo reports that PHAXIAM Therapeutics has not experienced any cybersecurity incidents.

How many peer or competitor companies does PHAXIAM Therapeutics have ?

PHAXIAM Therapeutics has an estimated 1,077 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

PHAXIAM Therapeutics

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

PHAXIAM Therapeutics Vendor Cyber Rating & Cyber Score

phaxiam.com

Add Your Compliance Badge

PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC

PHAXIAM Therapeutics A.I CyberSecurity Scoring

Scoring History

PHAXIAM Therapeutics

PHAXIAM Therapeutics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

PHAXIAM Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for PHAXIAM Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for PHAXIAM Therapeutics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for PHAXIAM Therapeutics in 2026.

Incident Types PHAXIAM Therapeutics vs Biotechnology Industry Avg (This Year)

No incidents recorded for PHAXIAM Therapeutics in 2026.

Incident History - PHAXIAM Therapeutics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

PHAXIAM Therapeutics Subsidiaries

Parent Company

PHAXIAM Therapeutics

Biotechnology

Website: http://www.phaxiam.com

Company Size: 61

No subsidiary data available for this company.

Loading…

PHAXIAM Therapeutics Similar Companies

Regeneron

cb regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

PHAXIAM Therapeutics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

June 17, 2025 07:00 AM

PHAXIAM Therapeutics Announces the Suspension of Trading in Its Shares Until Delisting

LYON, France, June 18, 2025--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), hereinafter referred to as "the Company"...

Read Article

June 12, 2025 07:00 AM

PHAXIAM Therapeutics Announces Judicial Liquidation and Delisting

LYON, France, June 12, 2025--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), hereinafter referred to as "the Company"...

Read Article

March 11, 2024 07:00 AM

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market | PHXM Stock News

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53532

SUMMARY

OpenEXR is the reference implementation and specification for the EXR image format, widely used in the motion picture industry. In versions 3.4.0 through 3.4.12, a crafted HTJ2K-compressed EXR file causes an unconditional process abort in any application that calls exr_start_read() on untrusted input, resulting in denial of service. The crash is triggered by a QCD marker whose lower five bits are zero, which OpenEXR passes into the vendored OpenJPH library while constructing the codestream and evaluating its quantization delta parameters. OpenJPH uses an assertion rather than a recoverable error to validate those bits, so any invalid value calls abort() directly and cannot be intercepted by surrounding error handling, a problem compounded by OpenEXR wrapping only its internal HT header parser in error handling while leaving the later codestream read and construction calls unprotected. This issue has been resolved in version 3.4.13.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-78435

SUMMARY

A vulnerability has been found in Faveo Helpdesk up to 2.0.3. Affected is the function unlink of the file app/Http/Controllers/Admin/helpdesk/SettingsController.php of the component Logo Handler. Such manipulation of the argument data1 leads to path traversal. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 3.8)

cvss2

Base Score: 4.7

Complexity: LOW

AV:N/AC:L/Au:M/C:N/I:P/A:P

cvss3

Base Score: 3.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

1.2

REFERENCES

CVE-2026-78434

SUMMARY

A flaw has been found in Faveo Helpdesk up to 2.0.3. This impacts the function FormController::post_ticket_reply of the file app/Http/Controllers/Client/helpdesk/FormController.php of the component post-ticket-reply Endpoint. This manipulation causes missing authentication. The attack can be initiated remotely. The exploit has been published and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 6.5)

cvss2

Base Score: 6.4

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:P

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-78284

SUMMARY

Unauthenticated Arbitrary File Deletion in MasterStudy LMS <= 3.7.42 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/masterstudy-lms-learning-management-system/vulnerability/wordpress-masterstudy-lms-plugin-3-7-42-arbitrary-file-deletion-vulnerability?_s_id=cve

CVE-2026-78282

SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Stripe Payments <= 2.1.2 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/stripe-payments/vulnerability/wordpress-stripe-payments-plugin-2-1-2-cross-site-scripting-xss-vulnerability?_s_id=cve

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…